Scientists at Mass General Brigham in Boston have developed an AI tool called FaceAge, an algorithm designed to tell patients ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

OmniAb's reliance on licensing transgenic animals for drug discovery faces risks with FDA shifts and cash burn issues. Learn ...

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

The FDA is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, part of a bid to get faster and leaner in evaluating drugs, foods, medical devices and diagnostic ...

Johns Hopkins University School of Medicine received a $10 million donation for an endowed AI center to further research and innovation in clinical and non-clinical spaces. There is rapid evolution of ...

Meanwhile, Axios reports the FDA is making plans to use AI in its decision-making. Also: President Donald Trump is set to sign an executive order to bring down the cost of meds.

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

The U.S. Food and Drug Administration (FDA) has unveiled a historic initiative to implement artificial intelligence (AI) ...

For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

Damo Panda, an AI model used for early pancreatic cancer screening, has been officially designated as a breakthrough device by the US Food and Drug Administration (FDA), said its developer ...